Biotech License

Monoclonal Antibody against the human MC4R as a Treatment of Weight Loss

Sunday, August 1st, 2010 Posted in Biotech Licensing | No Comments »

Pharmaceutically active monoclonal antibody, human melanocortin-4 receptor (MC4R), treatment of weight loss, anorexia / cachexia, modulation of appetite and food intake, compositions including such mAbs or binding fragments thereof Read more..

E-OA-07 – A Support formula for Osteoarthritis

Saturday, July 31st, 2010 Posted in Biotech Licensing | No Comments »

A clinically proven safe and effective innovative research formula to sustain healthy joints, promote joint flexibility and mobility and give comfort against stiffness and pain. Read more..

ibuprofen oral suspension

Thursday, July 29th, 2010 Posted in Biotech Licensing | No Comments »

Need to in-license Ibuprofen Oral suspension for UK Read more..

ErbB peptides for treating cancer

Wednesday, July 28th, 2010 Posted in Biotech Licensing | No Comments »

Novel peptides for treating a large variety of cancers. The erbB receptor family is expressed in a variety of different human tumors including breast, head and neck, gastric, colorectal, ... Read more..

Bovine TB test kit

Sunday, July 25th, 2010 Posted in Biotech Licensing | No Comments »

Fluid-based bio-optical sensor and portable reader Read more..

Methods and Compositions for Promoting Hair Growth: Treatment of Male and Female Androgenic Alopecia

Saturday, July 24th, 2010 Posted in Biotech Licensing | No Comments »

Methods and Compositions for Promoting Hair Growth: Treatment of Male and Female Androgenic Alopecia Read more..

Loratadine orally disintegrating tablets 5mg and 10mg

Friday, July 23rd, 2010 Posted in Biotech Licensing | No Comments »

Rubicon has developed a generic equivalent, pleasant tasting, robust, stable orally disintegrating tablets of Loratadine which can be packed in unit dose blister packs and offers product launching opportunity in ... Read more..

Banner offers Ibuprofen softgel capsules for out licensing

Friday, July 16th, 2010 Posted in Biotech Licensing | No Comments »

Both 200mg and 400mg strengths are available on CTD dossier with sufficient BE studies in clear colourless, pink and blue Read more..

1.Single compound for osteoarthritis treatment which contains KH-207 as the cartilage regeneration agent(KH-207), 2. Herbal pharmaceutical composition for regenerative agent of cartilaginous tissue and treatment of osteoarthritis(KD-30)

Wednesday, July 14th, 2010 Posted in Biotech Licensing | No Comments »

Our products (KH-207 and KD-30) related to treatment of osteoarthritis focus on increase of chondrogenesis through cartilage protection as well as beneficial effects (decrease of pain and stiffness and improvement ... Read more..

Gadopentetate dimeglumine

Sunday, July 11th, 2010 Posted in Biotech Licensing | No Comments »

To look for outlicensing opportunity around the world Read more..